Joint Formulary Newsletter
Bedfordshire and Luton Joint Formulary Newsletter
July 2020, Number 4
Incorporates Key Recommendations from The Bedfordshire and Luton Joint Prescribing Committee (JPC) 1st July 2020
The Bedfordshire and Luton Joint Formulary (a combined medicines formulary for use by BCCG, LCCG, Bedford Hospital and the Luton and Dunstable University Hospital) is now ‘live’. It can be accessed here
Unless otherwise stated decisions made apply to all organisations in the Joint Formulary Group.
|FORMULARY TRAFFIC LIGHT STATUS INFORMATION|
|RED||RED - Hospital Only - to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment|
|AMBER||Amber medicines are considered suitable for GP prescribing following specialist initiation|
|GREEN||These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations|
|SCG||Shared Care - These medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place, status reverts to RED.|
|BLACK||A decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. DO NOT PRESCRIBE|
|The following ADDITIONS to the Joint Formulary were agreed at the JPC Committee Meeting|
The Committee approved the bulletin and addition of Prucalopride to the Joint Formulary for use in men in accordance with the criteria set out in NICE TA 211 for women. Specialist to initiate and GP to continue prescribing (amber).
|Hospital Drug and Therapeutic Committee Updates|
Luton and Dunstable Hospital DTC
Formulary Addition – Probiotic drops (Labinic) for preterm infants to prevent necrotising enterocolitis
Formulary Addition – Remdesivir – MHRA EAMS (as part of the COVID 19 response). Retrospective DTC approval will be sought.
|CCG Prescribing Committees|
BCCG Prescribing Committee
LCCG prescribing committee
|Wound Care Formulary Group (Ratified by the JPC)|
• No update from the Wound Care Group
|Decisions Made By Joint Formulary Group (Ratified by the JPC)|